Fund+
Biotechnology · Venture Capital
$121.1Mraised by its portfolio in 12 months
16open roles in its portfolio
19investments
4exits
Overview
Fund+ is a Belgian life sciences investment fund backing innovative biotechnology and medical technology companies. It provides long-term capital to companies developing new therapies, diagnostics and devices, investing mainly in Belgium and elsewhere in Europe. The fund was established in 2015, is based in Leuven, Belgium, and is backed by a group of private investors, family offices and institutional shareholders.
Key facts
These are the key facts about Fund+ on Alion as of Nov 13, 2026. Fund+ is headquartered in Leuven, Belgium. It was founded in 2015.
- Headquarters
- Leuven, BelgiumAlion company profile, updated Sep 17, 2026
- Founded
- 2015Alion company profile, updated Sep 17, 2026
- Employees
- 50+Alion company profile, an estimated range
Official records
Investor profile
Venture capitalInvestments
19
6 of them startups
Hiring now
1
16 open roles
Rounds in 12 months
3
$121.1M raised
Exits
4
Focusshare of its companies
Health Care 73%Biotechnology 45%Events & Ticketing 9%
Where its companies are
Germany 5%United States 5%France 5%
Stage of its companies
Series B 50%Series A 50%
Its companies, the freshest money firstAll 19 investments
NovadipVenture round $11.2M · 1 mo ago
Ona TherapeuticsSeries B $86.6M · 5 mo ago
TargEDSeries A $23.2M · 10 mo ago
MinoryxVenture round $55.1M · 4 yr ago
Immunic TherapeuticsVenture round · 9 yr ago · 16 roles
Indigo • BTW BE 0666
EyeD Pharma
promethera.com
etherna
EPICS Therapeutics
Coave Therapeutics
ExeVir
Hiring fastestroles opened in 30 days
Co-investorscompanies they hold together
Similar investorstheir companies share markets and countries
Sources: its portfolio page, read Nov 3
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Leuven
Belgium
HQ
50-200 est. staff
How to cite this page
Alion, "Fund+: key facts", as of Nov 13, 2026. https://alion.io/company/fund-plus
These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0

V-Bio Ventures
Kurma Partners
Ysios Capital
Omega Funds
Newton Biocapital
Westlake BioPartners
RA Capital Management
EcoR1 Capital
Sofinnova Investments
Jeito Capital
LAV
Flerie